HUBS vs TTRX · P/E 96, rev $1.79B vs $187.1M cap
HubSpot Inc (HUBS) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
TTRX does not have a complete income-statement cache yet.
HUBS currently screens at market cap $9.36B and trailing P/E 96.2. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the HUBS and TTRX stock pages for the full models.
Not investment advice.